This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Jiang Qingping acquired 5% stake in Nanjing Zhiyou Shangyun Technology Co., Ltd. CI
Elefirst Science and Technology Co., Ltd.(SZSE:300356) dropped from Shenzhen Stock Exchange A Share Index CI
Elefirst Science and Technology Co., Ltd.(SZSE:300356) dropped from Shenzhen Stock Exchange Composite Index CI
Elefirst Science and Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Elefirst Science and Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Elefirst Science and Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Elefirst Science and Technology Co., Ltd. Announces Board Appointments CI
Jiang Qingping agreed to acquire 5% stake in Nanjing Zhiyou Shangyun Technology Co., Ltd. CI
Elefirst Science and Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Elefirst Science and Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
EleFirst Science & Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Elefirst Science & Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
EleFirst Science & Technology : Shenzhen Bourse Assigns Risk Alert Status to Elefirst's Shares MT
EleFirst Science & Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Elefirst Science & Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
EleFirst Sci & Tech's Controlling Shareholder Scraps Plan to Sell Stake CI
Elefirst Science & Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Elefirst Science & Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020 CI
Nanjing Runyi Enterprise Management Partnership signed a share transfer agreement to acquire 5.64% stake in EleFirst Science & Technology Co., Ltd. from Jiangsu Guangyi Investment Management Co., Ltd. for approximately CNY 130 million. CI
Elefirst Science & Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Foshan Xiaobang Equity Investment Partnership Enterprise (Limited Partnership) cancelled the acquisition of 3% stake in Unionman Technology Co., Ltd. from EleFirst Science & Technology Co., Ltd.. CI
EleFirst Science & Technology's Shareholders Plan to Unload Stakes in the Company CI
Elefirst Science & Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019 CI
Elefirst Science & Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019 CI
Elefirst Science & Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019 CI
Chart Elefirst Science and Technology Co., Ltd.
More charts
SHENZHEN CAU TECHNOLOGY CO., LTD is a China-based company principally engaged in the biomedical business. The Company is principally involved in the research, development, manufacture and sale of pharmaceutical products. The Company's main products include compound dichloroacetic acid diisopropylamine for injection, amifostine for injection, clindamycin phosphate for injection and urokinase for injection. The Company distributes its products in domestic market.
More about the company
  1. Stock Market
  2. Equities
  3. 300356 Stock
  4. News Elefirst Science and Technology Co., Ltd.
  5. EleFirst Science & Technology : Shenzhen Bourse Assigns Risk Alert Status to Elefirst's Shares